Shim Kyoung Jae News Today : Breaking News, Live Updates & Top Stories | Vimarsana

HLB, awaiting new drug approval in the U.S. for its liver cancer drug Rivoceranib, said Tuesday its liver cancer treatment improved the conditions of patients who were deemed inoperable.

Baek byung yeulDrug administrationJin yang gonJiangsu hengruiShim kyoung jaeSouth koreaHe korea timesOrea timesOrean news in english